GILLIBRAND, SCOTT PRESS FDA ON SHORTAGE OF CANCER DRUGS

WASHINGTON, Aug. 5 -- Sen. Kirsten Gillibrand issued the following press release:

Today, U.S. Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the Senate Aging Committee, pressed the Food and Drug Administration (FDA) on what actions it is taking to alleviate the shortage of critical cancer medications.

"We must do everything we can to make sure no cancer patient goes without life-saving chemotherapy drugs," said Senator Gillibrand. "However, addressing this crisis cannot come at the expense of patient safety or a secure supply chain. Senator Scott and I are pressing the FDA to develop a plan to fix the drug shortage while also ensuring that imported drugs are up to American regulatory standards." ...